Welcome to Add-Aspirin
This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.
Add-Aspirin is a large randomised clinical trial, which is taking place in the UK, Republic of Ireland and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.
Congratulations to our top 5 recruiting centres:
- University Hospitals Coventry & Warwickshire
- Worcestershire Royal Hospital
- Tata Memorial Hospital, Mumbai
- Royal Marsden Hospitals
- Queen Elizabeth Hospital, King's Lynn
*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR FAQs*
News
'Daily aspirin unlikely to help healthy older people live longer, study finds'
A clinical trial looking at use of daily aspirin in healthy people aged 70 or over, has suggested that there is no overall benefit, when considering risk of death, dementia or physical disability.
The trial involved 19,000 healthy individuals aged 70 years or older, who were asked to take either a low-dose (100mg) aspirin tablet or a placebo (dummy) tablet daily for 5 years. The numbers of people who died or were diagnosed with dementia or a physical disability were similar in the two groups. Aspirin also did not appear to reduce the number of people having a heart attack or stroke as has been seen in studies of other groups of people (such as those with a higher than average risk of these events).
Quick Links
To RANDOMISE a participant from the UK please call +44 (0)20 7670 4777
To RANDOMISE a participant from Republic of Ireland or India only, please use the 'Register a participant' link above to randomise online. Please make sure to press 'Randomise' once logged in to the server.
Unblind a participant in the UK
Breast
We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer.
CURRENT STATUS:
OPEN
Detailed eligibility criteria available here
Top recruiters: UHCW, Worcestershire Royal Hospital, Tata Memorial Hospital Mumbai, Royal Marsden Hospitals,
PARTICIPANTS REGISTERED: 2515
PARTICIPANTS RANDOMISED: 2034
Colon/Rectum
We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer.
CURRENT STATUS:
OPEN
Detailed eligibility criteria available here
Top recruiters: Bristol Haematology & Oncology Centre, St James 's University Hospital, Darlington Memorial Hospital
PARTICIPANTS REGISTERED: 1460
PARTICIPANTS RANDOMISED: 1151
Gastro
We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).
CURRENT STATUS:
OPEN
Detailed eligibility criteria available here
Top recruiters:
Tata Memorial Hospital Mumbai, The Christie, St James's University Hospital,
PARTICIPANTS REGISTERED: 266
PARTICIPANTS RANDOMISED: 208
Prostate
We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer.
CURRENT STATUS:
OPEN
Detailed eligibility criteria available here
Top recruiters: UCHW, University Hospital of Wales, Bristol Haematology & Oncology Centre
PARTICIPANTS REGISTERED: 1181
PARTICIPANTS RANDOMISED: 961
the trial is being jointly funded by
